Registry of patients with inflammatory and autoimmune diseases with SARS-CoV2 infection

  • Funded by National Institute of Health Carlos III [El Instituto de Salud Carlos III] (ISCIII)
  • Total publications:0 publications

Grant number: COV20_01138

Grant search

Key facts

  • Disease

    COVID-19
  • Funder

    National Institute of Health Carlos III [El Instituto de Salud Carlos III] (ISCIII)
  • Principal Investigator

    Ricardo Blanco Alonso, Miguel Ángel González-Gay
  • Research Location

    Spain
  • Lead Research Institution

    FUNDACION INSTITUTO DE INVESTIGACION MARQUES DE VALDECILLA (IDIVAL)
  • Research Priority Alignment

    N/A
  • Research Category

    Epidemiological studies

  • Research Subcategory

    Disease susceptibility

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

The project tries to generate a registry of all patients diagnosed with SARS-CoV2 infection and previously diagnosed rheumatological disease. To do this, EHR data will be collected from SARS-CoV2 + patients and rheumatological diseases in relation to their underlying disease, their previous treatment, the treatment that was being used when the symptoms of infection began, the course of the disease until its resolution, including the appearance of complications, the therapies used as treatment and the presence of risk factors. The objective is to subsequently analyze the data obtained in order to determine what is the influence of rheumatological diseases in the course of infection and if the therapies administered can be beneficial or harmful in terms of prophylaxis and / or less or greater severity of the disease. infection.